Reply to letter to the Editor: "Possible intermediary role of autophagy in serum albumin decrease-associated cardiovascular events among patients with coronary heart disease"

被引：1
|
作者：
Chien, Shih-Chieh [1 ]
Yeh, Hung-I [2 ]
机构：
[1] MacKay Mem Hosp, Dept Crit Care Med, Taipei, Taiwan
[2] Mackay Med Coll, MacKay Mem Hosp, Dept Internal Med, Cardiovasc Div, New Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2018年 / 250卷
关键词：
Serum albumin; Autophagy; Coronary heart disease;
D O I：
10.1016/j.ijcard.2017.09.212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [41] Assessment of the Role of Serum 25-Hydroxy Vitamin D Level on Coronary Heart Disease Risk With Stratification Among Patients With Type 2 Diabetes Mellitus
    Bener, Abdulbari
    Al-Hamaq, Abdulla O. A. A.
    Zughaier, Susu M.
    Ozturk, Mustafa
    Omer, Abdulkadir
    ANGIOLOGY, 2021, 72 (01) : 86 - 92
  • [42] Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
    Holme, Ingar
    Cater, Nilo B.
    Faergeman, Ole
    Kastelein, John J. P.
    Olsson, Anders G.
    Tikkanen, Matti J.
    Larsen, Mogens Lytken
    Lindahl, Christina
    Pedersen, Terje R.
    ANNALS OF MEDICINE, 2008, 40 (06) : 456 - 464
  • [43] Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
    Huang, Juan
    Gu, Jun-Xu
    Bao, Hui-Zhang
    Li, Shan-Shan
    Yao, Xiao-Qin
    Yang, Ming
    Li, Yang
    Zhang, Ai-Min
    Yin, Yue
    Zhang, Na
    Jia, Mei
    Su, Ming
    DISEASE MARKERS, 2021, 2021
  • [44] Growth differentiation factor 15 is independently associated with cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study
    Dallmeier, D.
    Mons, U.
    Brenner, H.
    Koenig, W.
    Rothenbacher, D.
    EUROPEAN HEART JOURNAL, 2014, 35 : 226 - 226
  • [45] Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease"
    Simes, John
    Kirby, Adrienne
    Tonkin, Andrew
    CIRCULATION, 2019, 139 (09) : 1245 - 1246
  • [46] Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
    Koenig, Wolfgang
    Twardella, Dorothee
    Brenner, Hermann
    Rothenbacher, Dietrich
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) : 1586 - 1593
  • [47] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) MAY PREDICT FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE (CHD) AND ISCHEMIC CEREBRAL STROKE (iCI)
    Bartko, D.
    Blazicek, P.
    Combor, I.
    Gombosova, Z.
    Danihel, L.
    Fabcin, J.
    Prieselova, Z.
    Lietava, J.
    Tupy, J.
    Polakovicova, J.
    Hrouda, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 94 - 94
  • [48] In Reply to the Letter to the Editor Regarding ? Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease ?
    Terrell, Danielle
    Savardekar, Amey R.
    Whipple, Stephen Garrett
    Sun, Hai
    WORLD NEUROSURGERY, 2020, 138 : 583 - 584
  • [49] Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study
    Zhao, Zi-wen
    Xu, Yi-wei
    Li, Shu-mei
    Guo, Jin-jian
    Yi, Tao
    Chen, Liang-long
    BIOCHEMIA MEDICA, 2019, 29 (01) : 84 - 93
  • [50] Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience
    Chen, Yundai
    Yang, Xinchun
    Vinh Nguyen Pham
    Huang, Shian
    Fu, Guosheng
    Chen, Xiaoping
    Binh Quang Truong
    Yang, Yu
    Liu, Shaowen
    Chen, Xuan
    Ma, Tianrong
    Kim, Dong-Soo
    Kim, Tae-Hoon
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 217 - 225
12345